ESC/X
Jun 2, 2025, 08:27
“Tobacco and Thrombosis: Sex-Specific Cardiovascular Risks in Focus on World No Tobacco Day” – Dr. Maja Lisa Løchen Highlights ESCPrev2025
The European Society of Cardiology (ESC) sheds light on the sex-specific differences in tobacco addiction and cardiovascular risk, as highlighted by Dr. Maja Lisa Løchen at ESCPrev2025
“Emerging evidence indicates that smoking contributes differentially to cardiovascular disease (CVD) and thrombotic risk in men and women, necessitating a tailored preventive strategy. The burden of platelet activation, endothelial dysfunction, and hypercoagulability linked to tobacco use may disproportionately affect women, particularly in the presence of other risk factors such as hormonal therapy or autoimmune disorders.”
Watch the full presentation on ESC365:
Let today be a call to action for personalized CVD prevention and smoking cessation strategies that account for biological and behavioral sex differences.
You will find more exciting news in Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis